Korea Bio-Gen Co.Ltd Cash Flow Reinvestment Rate
Korea Bio-Gen Co.Ltd cash flow reinvestment rate. Korea Bio-Gen Co.Ltd (318000) has a Cash Flow Reinvestment Rate of 0.49x as of June 2026, reinvesting ₩736.81 Million (capex ₩40.03 Million plus investments ₩-696.77 Million) from operating cash flow of ₩1.51 Billion. Explore how well can Korea Bio-Gen Co.Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Korea Bio-Gen Co.Ltd (2017–2025)
Cash flow reinvestment rate of Korea Bio-Gen Co.Ltd from 2017 to 2025. Historical reinvestment intensity for Korea Bio-Gen Co.Ltd across 9 annual periods. Explore 318000 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Korea Bio-Gen Co.Ltd Cash Flow Reinvestment Rate by Year (2017–2025)
Korea Bio-Gen Co.Ltd cash flow reinvestment rate by year from 2017 to 2025. Year-by-year capital reinvestment analysis for Korea Bio-Gen Co.Ltd. For the full cash flow conversion analysis, see Korea Bio-Gen Co.Ltd operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.11x | ₩8.12 Billion | ₩7.34 Billion | ₩462.42 Million | ▼ -33.5% |
| 2024 | 1.66x | ₩7.14 Billion | ₩4.29 Billion | ₩5.12 Billion | ▲ +86.3% |
| 2023 | 0.89x | ₩8.45 Billion | ₩9.47 Billion | ₩2.42 Billion | ▼ -63.9% |
| 2022 | 2.48x | ₩4.13 Billion | ₩1.67 Billion | ₩2.29 Billion | ▼ -26.7% |
| 2021 | 3.38x | ₩10.44 Billion | ₩3.09 Billion | ₩2.36 Billion | ▲ +563.3% |
| 2020 | 0.51x | ₩1.31 Billion | ₩2.58 Billion | ₩872.46 Million | ▼ -83.7% |
| 2019 | 3.12x | ₩9.53 Billion | ₩3.05 Billion | ₩2.55 Billion | ▲ +636.5% |
| 2018 | 0.42x | ₩840.93 Million | ₩1.98 Billion | ₩840.93 Million | ▼ -24.6% |
| 2017 | 0.56x | ₩777.66 Million | ₩1.38 Billion | ₩777.66 Million | — |